[Development and integration of ASP assessment tools for bacteraemia and infections caused by multidrug-resistant microorganisms in paediatrics]. [PDF]
Echávarri-de-Miguel M +6 more
europepmc +1 more source
From voluntary efforts to established procedures: the communication our patients need. [PDF]
Baixauli Fernández VJ.
europepmc +1 more source
Clinical and functional evidence supporting pathogenicity of a novel APOA5 variant in familial chylomicronemia syndrome. [PDF]
Gutiérrez J +14 more
europepmc +1 more source
Interpretation of the ambulatory glucose profile in diabetes: practical application in community pharmacy. [PDF]
García Soláns JR.
europepmc +1 more source
Correction: Management of patients with protein s deficiency: focus on clinical course and direct oral anticoagulants. [PDF]
Altamura N +14 more
europepmc +1 more source
Management of Nocturnal Hypoglycaemia in a Patient with Type 2 Diabetes: The Role of Community Pharmacy. [PDF]
Nadal Domingo S +2 more
europepmc +1 more source
[Treatment with dabrafenib and trametinib in an intrahepatic cholangiocarcinoma harboring a BRAF V600E mutation]. [PDF]
Gámiz Rejano A +2 more
europepmc +1 more source
Correction to: Modern and multidisciplinary care in polycythemia vera. [PDF]
Palandri F +20 more
europepmc +1 more source
Pharmacotherapeutic Optimization in a Polymedicated Patient Through Coordinated Pharmaceutical Intervention: A Community Pharmacy Case Report. [PDF]
Vera Peña A +5 more
europepmc +1 more source
Clinical relevance of cytochrome P450-mediated drug-drug interactions in hospitalised older adults: implications for community pharmacy. [PDF]
Lozano R, Bona C.
europepmc +1 more source

